Trial Profile

A Phase 1 clinical trial for VTB-10 for pulmonary arterial hypertension

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 17 Oct 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs VTB 10 (Primary)
Indications Pulmonary arterial hypertension
Focus Adverse reactions

Most Recent Events

17 Oct 2025 New trial record
19 Aug 2025 According to VASTHERA media release, company announced that it has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) to initiate a Phase 1 clinical trial for VTB-10for pulmonary arterial hypertension (PAH)
31 Jul 2025 According to VASTHERA media release, The first patient administration is expected to take place in the second half of this year.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com